Document:

China Power Technology, Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

Exhibit 10.1

AMENDMENT NUMBER 3 TO SECURITIES PURCHASE AGREEMENT

THIS AMENDMENT NUMBER 3 TO SECURITIES PURCHASE AGREEMENT, dated
as of December 20, 2010 (this “Amendment”), is entered into by and among
China Power Technology, Inc., a Nevada corporation (collectively with its
predecessors, the “Company”) and the Investors. Capitalized terms used
herein but not otherwise defined herein shall have the respective meanings set
forth in the Securities Purchase Agreement (as defined below). 

BACKGROUND 

The Company and the Investors are parties to that certain
Securities Purchase Agreement, dated as of June 16, 2010 (the “Securities
Purchase Agreement”). The Investors understand that certain underwriters
(the “Underwriters”) propose to enter into an underwriting agreement with
the Company providing for the public offering (the “Public Offering”) by
the Company of shares of Common Stock of the Company. To induce the Underwriters
that may participate in the Public Offering to continue their efforts in
connection with the Public Offering, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties to this Amendment wish to amend certain provisions of the Securities
Purchase Agreement as set forth in this Amendment.

Section 6.4 of the Securities Purchase Agreement provides that
no provisions of the Securities Purchase Agreement may be waived or amended
except in a written instrument signed by the Company and the Requisite Holders.
This Amendment constitutes a written agreement signed by the necessary parties
in order to effectuate the amendments to the Securities Purchase Agreement
specified below.

NOW, THEREFORE, in consideration of the foregoing and the
respective covenants and agreements set forth herein, the parties hereto agree
as follows: 

Section 1. The parties hereto agree that the definition
of “Qualified Public Offering” under Section 1.1 is hereby amended and restated
in its entirety as follows: 

“Qualified Public Offering” means an underwritten public
offering conducted by the Company in which it raises gross proceeds of at least
$30 million and the Company’s common stock is listed concurrently or prior
thereto on a Trading Market (other than the OTCBB).” 

Section 2. Except as amended hereby, the Securities
Purchase Agreement as amended by Amendments No. 1 and 2, shall remain in full
force and effect.

Section 3. This Amendment may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. 

[SIGNATURE PAGE FOLLOWS] 

1 

IN WITNESS WHEREOF, the parties hereto have caused this
Amendment to be duly executed by their respective authorized signatories as of
the date first indicated above. 

COMPANY: 

CHINA POWER TECHNOLOGY,
INC.

By: /s/ Honghai
Zhang                  

      Name: Honghai Zhang

      Title: Chief Executive Officer 

REQUISITE HOLDERS: 

SUN FOREVER LIMITED

By: /s/ Gang
Wang                            

      Name: Gang Wang 
 
    Title: Managing PartnerExhibit 4.20

 

EXTENSION AGREEMENT  

 

September 16, 2010

This Extension Agreement (this “Agreement”) is entered into by and between IASO Pharma Inc. (f/k/a Pacific Beach Biosciences, Inc.), a Delaware corporation (the “Company”) and each of the noteholders listed on the signature pages hereto (together with successors and assigns of each, a “Holder,” and collectively, the “Holders”) to extend the maturity of the series of like senior convertible promissory notes (collectively, as previously amended, the “Bridge Notes”) in the aggregate principal amount of $4,340,000 sold by the Company in a private placement pursuant to Note and Warrant Purchase Agreements dated as
of December 14, 2007 (collectively, as previously amended, the “Purchase Agreements”).  

RECITALS

WHEREAS, each of the Holders and the Company are party to the Purchase Agreements and Bridge Notes; 

WHEREAS, the Bridge Notes mature pursuant to their terms on September 30, 2010; 

WHEREAS, each of the undersigned Holders agrees to amend the Bridge Notes solely to extend the maturity of the Bridge Notes on the terms set forth herein; and

WHEREAS, such amendment requires the written consent of the Company and the holders of not less than sixty-six and two-thirds percent (66 2/3%) of the aggregate outstanding principal amount of the Bridge Notes (the “Requisite Approval”) pursuant to Section 6.2 of the Purchase Agreements and Section 11 of the Bridge Notes, respectively.  

	
            NOW, THEREFORE, the parties agree as follows:
 

1.         Amendment; Extension.  Each of the Bridge Notes is hereby amended to extend the Due Date of such Bridge Note from September 30, 2010 to December 31, 2010.

2.        Representations and Warranties of the Holders.  Each of the Holders party hereto hereby represents and warrants to the Company that: 

 (a)         the Holder is the lawful holder of the Bridge Note designated on the signature page hereto free and clear of all security interests, claims, liens, pledges, conditional sales contracts, attachments, judgments and encumbrances of every kind and nature, including restrictions, or rights of any third parties;

 

 (b)        the Holder has the requisite power and authority to execute and deliver this Agreement, to perform the Holder’s obligations hereunder and to engage in the transactions contemplated hereby;

 

 (c)         the Holder has taken all requisite action to make all the provisions of this Agreement the valid and enforceable obligations they purport to be; and

 

 

 

 (d)        this Agreement constitutes the valid and binding obligation of the Holder, enforceable in accordance with its terms, subject to laws of general application from time to time in effect affecting creditors' rights and the exercise of judicial discretion in accordance with general equitable principles.

 

	
             
 	
            3.
 	
            Miscellaneous
 

(a)          This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.  In the event that any signature is delivered by facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof. 

 (b)         This Agreement shall be governed by the law of the State of Delaware without giving effect to any principles or conflicts of law. 

 (c)          This Agreement shall be effective upon obtaining the signatures below of the Company and the Requisite Approval.  

 (d)         Except as expressly amended hereby, the terms of the Bridge Notes shall remain in full force and effect.

 (e)          Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 (f)         Existing references to any of the Bridge Notes are henceforth deemed references to the Bridge Notes as amended by this Agreement.

(g)       If any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, in whole or in part, the remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by law.

(h)       The headings contained in this Agreement are for reference purposes only and shall not be deemed to be part of the Agreement or to affect the meaning or interpretation of this Agreement.

(i)        All of the terms and provisions of this Agreement shall bind and inure to the benefit of the parties hereto and their respective successors and assigns.

(j)        This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person or entity.

 

[Remainder of page intentionally left blank]

 

2

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. 

	
             
 	
            IASO Pharma, Inc.
 
	
              
 	
              
 
	
              
 	
              
 
	
              
 	
            By: 
 	
            /s/ Matthew A. Wikler
 
	
              
 	
            Name: 
 	
            Matthew A. Wikler
 
	
              
 	
            Title: 
 	
            President and CEO
 
	
             
 	
             
 	
             
 	
             
 

  

	
            Principal Amount of Note:  $____________________  
 	
            HOLDER: 
 
	
              
 	
              
 
	
              
 	
            For Individuals 
 
	
              
 	
              
 
	
              
 	
              
 
	
              
 	
            Sign Name Above 
 
	
              
 	
              
 
	
              
 	
              
 
	
              
 	
            Print Name Above 
 
	
             
 	
             
 
	
             
 	
            _____________________________________  
 
	
             
 	
            Sign Name Above 
 
	
             
 	
              
 
	
             
 	
            _____________________________________  
 
	
             
 	
            Print Name Above 
 
	
              
 	
              
 
	
              
 	
            For Entities 
 
	
              
 	
              
 
	
              
 	
              
 
	
              
 	
            Print Name of Entity Above 
 
	
              
 	
              
 
	
              
 	
              
 
	
              
 	
            By: 
 	
              
 
	
              
 	
              
 	
            Name: 
 
	
              
 	
              
 	
            Title: 
 
	
             
 	
             
 	
             
 
	
             
 	
            By: 
 	
            ________________________________
 
	
             
 	
              
 	
            Name: 
 
	
             
 	
              
 	
            Title: 
 

 

 

Extension Agreement Signature Page

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}]]